Investment firm SouthRidge Capital is pleased to announce on February 11, 2010 that its affiliated fund has closed a private equity agreement with Puramed BioScience in the amount of $7.5 million in equity financing.
“Southridge is very pleased to provide equity capital financing for this innovative market leader in the over-the-counter consumer market for alternative health [...]
RSS